Short Decsription
Creative Biolabs offers CHO-K1-Tg(Human mu Receptor Y150A) Stable Cell Line which mu Mutant Y150A receptor stably expressed in CHO-K1 cells.
Description
CHO-K1-Tg(Human mu Receptor Y150A) Stable Cell Line was engineered to express the receptor human mu Mutant Y150A (NM_000914.2). The mu receptor mutant Y150A refers to a specific mutation in the mu-opioid receptor (MOR or μ-opioid receptor), where the tyrosine residue at position 150 is replaced with alanine. This cell line can be used to study mu receptor function, signaling pathways, and potential therapeutic interventions.
Features
Minimally modified GPCRs directly selected in functional assays;
Strict quality control;
Parental and orthologous cell lines are available.
Applications
mu receptor function, signaling pathways, and potential therapeutic interventions.
Protein Target
GPCR
Receptor Name
mu mutant Y150A
Receptor Family
Opioid
Species
Human
Parental Cell Line
CHO-K1
Transfection
Expression vector containing full-length human OPRM1 cDNA with Y150A mutation with FLAG tag sequence at N-terminus
Gene
NM_000914.2
Background
The mu-opioid receptor, often abbreviated as MOR or μ-opioid receptor, is a G protein-coupled receptor (GPCR) primarily known for its role in mediating the effects of endogenous opioids and opioid drugs. The mu-opioid receptor plays a pivotal role in pain modulation, reward processing, and addiction. Its complex physiological effects and clinical implications underscore ongoing efforts to understand its mechanisms and develop targeted therapies that balance therapeutic benefits with risks of misuse and dependence.

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2024 Creative Biolabs. All Rights Reserved.